Ewing sarcoma in a child with neurofibromatosis type 1

Area of Science:

• Oncology
• Genetics
• Pediatric Cancer

Background:

• Ewing sarcoma (ES) is a rare bone and soft tissue cancer primarily affecting children and young adults.
• Neurofibromatosis type 1 (NF1) is a genetic disorder that increases the risk of various tumors, but its association with ES is uncommon.
• The EWSR1-ERG fusion is a hallmark genetic alteration in most ES cases.

Observation:

• A pediatric patient with neurofibromatosis type 1 developed Ewing sarcoma.
• The tumor exhibited the characteristic EWSR1-ERG translocation.
• Crucially, the tumor also showed loss of the wild-type allele of the neurofibromatosis type 1 (NF1) gene.

Findings:

• Loss of the wild-type NF1 allele in the Ewing sarcoma tumor suggests its inactivation.
• Inactivation of NF1 leads to aberrant activation of the Ras signaling pathway.
• Analysis of public data indicates that Ras pathway mutations are present in approximately 3% of Ewing sarcoma cases.

Implications:

• This case highlights a potential mechanism for Ewing sarcoma development and progression in a subset of patients.
• Ras pathway activation, driven by NF1 loss, may be a key factor in tumor evolution.
• Further research into Ras pathway dysregulation in Ewing sarcoma could reveal novel therapeutic targets.